Anemia of Vitamin B 12 Deficiency Pernicious Anemia

Slide 1 · Anemia of vitamin B12 deficiency:Pernicious anemia

Autoimmune gastritis, impaired cobalamin absorption, and megaloblastic hematopoiesis

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Trace cobalamin from dietary release to ileal uptake and tissue delivery.

Explain how autoimmune gastric injury causes intrinsic-factor deficiency.

Connect cobalamin-dependent reactions to hematologic and neurologic injury.

Recognize morphology, diagnostic patterns, differentials, and response to replacement.

Slide 3 · Pernicious anemia: A linked multiorgan disorder

Autoimmunefundic gastritis

Loss ofintrinsic factor

Impaired B12absorption

Megaloblasticanemia

A gastric immune process produces a systemic hematologic deficit.

Neurologic abnormalities may occur in parallel, even without severe anemia.

Slide 4 · Pernicious anemia is not synonymous with all B12 deficiency

Pernicious anemia

Other B12-deficiency states

Autoimmune injury to gastric body/fundus

Dietary deficiency or nonautoimmune absorption defect

Loss of parietal-cell intrinsic factor

Multiple possible sites: stomach, pancreas, ileum

Atrophic gastritis persists after replacement

Underlying lesion depends on the cause

Slide 5 · Why cobalamin deficiency develops gradually

Vitamin B12 (cobalamin) is supplied chiefly by animal-derived foods.

The daily requirement is approximately 2–3 μg.

The liver stores sufficient B12 for several years with an adequate diet.

Clinical deficiency emerges when intake or uptake remains inadequate long enough to deplete stores.

Slide 6 · Dietary sources and the need for absorption

Meat, fish, milk, and eggs are major dietary sources.

Plants and vegetables contain little cobalamin.

Normal dietary supply does not prevent pernicious anemia when intrinsic factor is deficient.

Dietary history alone therefore cannot establish the mechanism of B12 deficiency.

Slide 7 · Normal vitamin B12 absorption: The pathway

Stomach:Food release

Duodenum:IF binding

Terminal ileum:Cubilin uptake

Blood:Transcobalamin II

Pepsin, haptocorrin, pancreatic proteases, and intrinsic factor act sequentially.

Failure at different steps can produce the same deficient state.

Slide 8 · Stomach: Release from dietary proteins

Dietary B12 is bound to food proteins.

Pepsin releases B12; It then associates with haptocorrin from saliva.

Loss of gastric acid–pepsin function can compromise food-bound B12 availability.

Slide 9 · Haptocorrin protects B12 in the stomach

Salivary haptocorrin binds liberated cobalamin.

The haptocorrin–B12 complex travels to the duodenum.

The next transfer requires pancreatic enzymes; IF does not bind food-derived B12 first.

Slide 10 · Duodenum: Transfer from haptocorrin to intrinsic factor

Pancreatic proteases digest haptocorrin.

Liberated B12 binds intrinsic factor (IF).

Exocrine pancreatic insufficiency can disrupt this transfer.

Slide 11 · Intrinsic factor originates from gastric parietal cells

Fundic parietal cells synthesize intrinsic factor.

IF binds B12 and supports receptor-mediated uptake in the terminal ileum.

Pernicious anemia results when immune-mediated gastric atrophy deprives the gut of IF.

Slide 12 · Ileal uptake requires cubilin

The IF–B12 complex reaches the terminal ileum.

Cubilin on ileal epithelial cells mediates complex binding and endocytosis.

Ileal disease or resection bypasses an otherwise intact stomach and pancreas.

Slide 13 · Transcobalamin II delivers absorbed vitamin B12

Inside ileal epithelial cells, B12 associates with transcobalamin II.

Bloodborne transcobalamin II carries B12 to the liver, marrow, gut, and other tissues.

Absorption is only the beginning: Highly proliferative tissues require sustained delivery.

Slide 14 · Why high-dose oral replacement can work

IF-dependentactive pathway fails

A small amountabsorbs passively

High oral doseincreases uptake

Passive intestinal absorption is inefficient, but it provides a route independent of the main IF–cubilin pathway.

Both parenteral and high-dose oral B12 can be used for replacement.

Slide 15 · Absorption failure can occur at multiple sites

Site of disruption

Consequence for B12 uptake

Stomach: achlorhydria / pepsin loss

Poor release of B12 from food

Stomach: parietal-cell loss / gastrectomy

Loss of intrinsic factor

Duodenum: pancreatic insufficiency

Failure to release B12 from haptocorrin

Ileum: resection or diffuse disease

Failure of IF–B12 uptake

Slide 16 · Only two human enzyme reactions require vitamin B12

Methionine synthase uses methylcobalamin.

Methylmalonyl-CoA mutase uses adenosylcobalamin.

Disruption affects folate recycling, DNA synthesis, and methylmalonate metabolism.

The mechanism of neurologic injury is less fully resolved than that of anemia.

Slide 17 · Methionine synthase links B12 to folate

Homocysteine

B12-dependentmethionine synthase

Methionine

The methyl donor is N5-methyl-tetrahydrofolate (N5-methyl-FH4).

The same reaction regenerates tetrahydrofolate (FH4) for one-carbon transfer reactions.

Slide 18 · The methyl-folate trap

B12 deficiency

Impaired methioninesynthase

Folate retained asN5-methyl-FH4

Reduced usableFH4 pool

This proposed metabolic trap reduces folate available for thymidylate synthesis.

Impaired production of metabolically active folate polyglutamates may also contribute.

Slide 19 · Thymidylate synthesis becomes limiting

Reduced FH4availability

Reduced N5,10-methylene-FH4

Impaired dUMPto dTMP conversion

Impaired DNAsynthesis

Thymidylate is required for DNA synthesis in dividing cells.

Cells continue cytoplasmic growth while nuclear maturation lags.

Slide 20 · Nuclear–cytoplasmic asynchrony explains megaloblasts

DNA synthesis and nuclear maturation are delayed.

Cytoplasmic protein synthesis and hemoglobin accumulation continue.

Erythroid precursors become large, with immature nuclear chromatin despite mature cytoplasm.

Slide 21 · From biochemical deficiency to pancytopenia

Impaired DNAsynthesis

Abnormal marrowprecursors

Marrow apoptosisand ineffective output

Anemia ± othercytopenias

The marrow can be hypercellular while peripheral counts are reduced.

High erythropoietic drive does not correct the underlying DNA synthetic block.

Slide 22 · The second cobalamin-dependent enzyme

Methylmalonyl-CoA

Adenosylcobalamin-dependent mutase

Succinyl-CoA

Loss of mutase activity in B12 deficiency causes methylmalonic acid accumulation.

Methylmalonate is a useful biochemical discriminator from folate deficiency.

Slide 23 · Methylmalonic acid rises in B12 deficiency

Adenosylcobalamin is the cofactor for methylmalonyl-CoA mutase.

Loss of enzyme activity increases methylmalonic acid in plasma and urine.

Homocysteine also rises through the methionine synthase pathway.

An elevated methylmalonate supports B12 deficiency, whereas isolated folate deficiency does not raise it.

Slide 24 · The neurologic mechanism remains incompletely explained

Abnormal methylmalonate and propionate metabolism has been proposed to alter neuronal lipids.

The proposed mechanism would predispose to myelin injury.

Hereditary mutase deficiencies do not reproduce the same characteristic cord syndrome.

The association is established; This particular causal explanation remains uncertain.

Slide 25 · Folate replacement and B12 replacement are not interchangeable

Hematologic effects

Neurologic effects

Folate may improve the anemia of B12 deficiency

Folate does not prevent B12-related neurologic injury

B12 replacement corrects the cobalamin-dependent hematologic deficit

Timely B12 treatment can halt or improve neurologic progression

Slide 26 · Autoimmune gastritis drives pernicious anemia

AutoreactiveT-cell response

Fundic mucosalinjury and atrophy

Parietal-celldepletion

IF deficiencyand B12 malabsorption

Autoantibodies are useful markers, but are not the primary initiators of mucosal injury.

The immune process precedes depletion of hepatic cobalamin reserves.

Slide 27 · The gastric fundus is the principal site of injury

Chronic atrophic gastritis affects the fundic mucosa.

Both parietal and chief cells are lost; Parietal cells may be virtually absent.

Gland atrophy is accompanied by lymphocytes and plasma cells.

Loss of the intrinsic-factor-producing cell population is central to B12 malabsorption.

Slide 28 · T cells initiate the mucosal lesion

An autoreactive T-cell response damages the gastric mucosa.

Loss of gastric glands and parietal cells is followed by autoantibody formation.

Serologic antibodies identify the immune process; They should not be interpreted as its sole pathogenic mechanism.

Slide 29 · Type I anti-intrinsic-factor antibodies

Antibody recognizes intrinsic factor.

It blocks B12 binding to IF and prevents normal complex formation.

Type I antibodies are present in about 75% of affected patients.

Slide 30 · Type II anti-intrinsic-factor antibodies

The IF–B12 complex may form.

Type II antibody prevents its normal interaction with the ileal cubilin receptor.

Both type I and type II antibodies may occur in plasma and gastric juice.

Slide 31 · Type III antibodies target the parietal-cell proton pump

The recognized antigen includes the α and β subunits of the gastric proton pump.

Type III antibodies are present in 85%–90% of affected patients.

They are not disease-specific; They may occur in idiopathic chronic gastritis in older adults.

An anti-parietal-cell result therefore differs from a highly specific anti-IF result.

Slide 32 · Autoantibodies: Functional target and interpretation

Autoantibody

Functional target / diagnostic meaning

Type I, anti-IF

Blocks B12 binding to IF; highly specific marker

Type II, anti-IF

Interferes with IF–B12 binding to ileal receptor

Type III, anti-parietal cell

Recognizes proton pump; less specific

Slide 33 · Why an immune lesion takes years to cause anemia

Gastric autoimmunity

Gradual declineof IF secretion

Long-term hepaticB12 depletion

Clinical deficiencyand cytopenias

The clinical lag reflects substantial pre-existing vitamin stores.

Once stores fall, rapidly dividing hematopoietic cells become vulnerable.

Slide 34 · Pernicious anemia usually appears in older adults

The median age at diagnosis is approximately 60 years.

Disease before age 30 is uncommon.

The disorder occurs across ethnic populations, despite some geographic differences in prevalence.

Genetic susceptibility is suspected; A simple Mendelian pattern is not established.

Slide 35 · Autoimmune comorbidity strengthens suspicion

Autoimmune thyroiditis is an important association.

Autoimmune adrenalitis is another reported association.

These associations support an underlying propensity to autoimmunity.

They do not replace direct evidence of cobalamin deficiency and its mechanism.

Slide 36 · B12 deficiency: Autoimmune and nonautoimmune pathways

Pernicious anemia

Other etiologies

Autoimmune fundic gland loss

Low dietary intake

Intrinsic factor deficiency

Gastrectomy or impaired food release

Persistent gastric lesion

Pancreatic or ileal malabsorption

Can coexist with other autoimmunity

Competition by intestinal parasites / overgrowth

Slide 37 · Insufficient dietary intake

Sustained intake without adequate cobalamin eventually exhausts hepatic stores.

Strictly vegetarian or macrobiotic diets may provide inadequate cobalamin.

The delay to anemia may be long because endogenous reserves are substantial.

Dietary deficiency does not itself imply autoimmune gastritis.

Slide 38 · Gastrectomy and impaired gastric digestion

Gastrectomy may remove the intrinsic-factor-producing mucosa.

Achlorhydria and reduced pepsin can impair release of food-bound B12.

The latter mechanism may occur in some older adults.

Both operate proximally but are mechanistically distinct.

Slide 39 · Exocrine pancreatic insufficiency

Normally pancreatic proteases cleave the haptocorrin–B12 complex.

Failure to release B12 prevents efficient transfer to intrinsic factor.

Ileal epithelium may be structurally normal despite deficient uptake.

The location of dysfunction explains the malabsorption.

Slide 40 · Ileal disease and ileal resection

The IF–B12 complex is absorbed in the terminal ileum.

Resection of the ileal segment can interrupt receptor-mediated uptake.

Diffuse ileal disease may have the same functional consequence.

Normal intrinsic factor cannot compensate for absent absorptive surface.

Slide 41 · Competition for intestinal cobalamin

Fish tapeworm infestation can compete for available B12.

Bacterial overgrowth in blind loops is another cause listed in the megaloblastic-anemia context.

Dietary adequacy does not exclude intestinal competition.

Exposure and anatomic history help localize the etiology.

Slide 42 · Nitrous oxide can functionally inactivate B12

Recreational nitrous oxide exposure oxidizes and inactivates cobalamin.

Biochemical deficiency and neurologic symptoms may appear despite a different underlying mechanism from pernicious anemia.

Exposure history matters when B12-related neurologic signs are prominent.

Slide 43 · Increased demand may produce relative deficiency

Increased demand is described in pregnancy, hyperthyroidism, disseminated cancer, and chronic infection.

These circumstances can expose a marginal supply of cobalamin.

They do not necessarily indicate intrinsic-factor deficiency.

Evaluate intake, absorption, and demand as separate axes.

Slide 44 · Localize the defect using physiology

Clinical clue

Likely disrupted step

Autoimmune gastric disease

Intrinsic factor production

Pancreatic insufficiency

Haptocorrin proteolysis

Terminal ileal resection

Cubilin-dependent uptake

Dietary restriction

Cobalamin input

Nitrous oxide exposure

Functional cobalamin activity

Slide 45 · Peripheral blood: A macrocytic production disorder

Macro-ovalocytes are highly characteristic of megaloblastic anemia.

There is variation in red cell size and shape: Anisocytosis and poikilocytosis.

Anemia can be severe and the reticulocyte response is inappropriately low.

Nucleated erythroid forms may circulate in marked disease.

Slide 46 · Macro-ovalocytes: A peripheral-smear schematic

Macro-ovalocytes: Exaggerated form (schematic)

Red cells are enlarged and often oval.

Apparent deep staining does not mean increased mean corpuscular hemoglobin concentration.

Actual morphology requires a genuine stained peripheral smear for diagnostic evaluation.

Slide 47 · Neutrophil hypersegmentation: A smear clue

Six-lobed nucleus: Simplified schematic

Neutrophils show increased nuclear lobation.

Hypersegmentation involves five or more nuclear lobes.

It supports a megaloblastic process but does not distinguish B12 from folate deficiency.

Slide 48 · Bone marrow: Hypercellularity despite cytopenia

Increased erythropoietic growth signals expand marrow precursors.

Defective DNA synthesis prevents effective terminal maturation.

Many precursors undergo intramedullary apoptosis.

Marrow hypercellularity therefore coexists with inadequate blood-cell production.

Slide 49 · Megaloblasts show nuclear–cytoplasmic asynchrony

Normal maturation

Delayed nuclear maturation

Nuclear chromatin cartoon (schematic)

Large erythroid precursors retain finely dispersed nuclear chromatin.

Hemoglobin accumulation proceeds despite delayed nuclear condensation.

Granulocytic precursors may be giant metamyelocytes or band forms.

Slide 50 · Ineffective erythropoiesis explains laboratory discordance

Marrow precursorexpansion

Nuclear maturationfailure

Increased cell deathin marrow

Low reticulocytesand anemia

The marrow response is quantitatively increased but qualitatively ineffective.

Other blood-cell lineages may also be affected, causing leukopenia and thrombocytopenia.

Slide 51 · Fundic atrophy removes the functional gastric glands

Preserved mucosa

Atrophic / metaplastic

Simplified gland architecture — not histology

Chronic gastritis produces loss of both parietal and chief cells.

Parietal cells may become virtually absent in established disease.

Glandular loss explains loss of intrinsic factor and impaired vitamin uptake.

Slide 52 · Intestinal metaplasia replaces fundic epithelium

Preserved mucosa

Atrophic / metaplastic

Simplified gland architecture — not histology

Mucus-producing intestinal-type goblet cells may replace gastric glands.

Some mucosal epithelial cells show megaloblastic enlargement.

Atrophy and metaplasia persist after B12 replacement.

Slide 53 · Atrophic glossitis: A visible mucosal consequence

The tongue can become smooth, shiny, and “beefy” in appearance.

This reflects epithelial changes in a rapidly renewing mucosal surface.

Glossitis is supportive but not specific to pernicious anemia.

Its presence should prompt correlation with blood morphology and nutritional status.

Slide 54 · Hematologic and gastric morphology respond differently

Reversible with B12

Persistent despite B12

Megaloblastic marrow change

Autoimmune fundic atrophy

Macrocytic anemia and low reticulocyte output

Established intestinal metaplasia

Mucosal megaloblastosis may improve

Underlying gastric carcinoma risk

Slide 55 · Spinal cord involvement: Major affected tracts

Dorsal columns

Lateral columns

Loss of proprioceptive pathway function

Motor pathway impairment

Sensory ataxia and altered position sense

Spasticity / paraparesis

Part of subacute combined degeneration

Part of subacute combined degeneration

Slide 56 · Subacute combined degeneration

Demyelination affects dorsal and lateral spinal tracts.

More advanced injury may be accompanied by axonal loss.

The clinical pattern includes sensory ataxia, spastic paraparesis, and paresthesias.

Neurologic pathology may appear without conspicuous hematologic disease.

Slide 57 · Neurologic symptoms require separate assessment

Peripheral neuropathic symptoms and severe lower-limb paresthesias may occur.

Posterior-root ganglia and peripheral nerves can also be affected.

Severe or longstanding neurologic damage may not fully reverse.

Hematologic normalization must not be used as the only measure of recovery.

Slide 58 · B12 neuropathy can precede anemia recognition

Cord and peripheral-nerve injury may develop independently of the severity of blood abnormalities.

A near-normal blood count cannot safely exclude clinically important cobalamin-related neurologic dysfunction.

Neurologic findings and exposure history warrant direct B12 evaluation.

Slide 59 · Clinical presentation is usually insidious

Anemia develops gradually over years as B12 reserves decline.

Symptoms may be substantial by the time the disorder is recognized.

Progression continues if the deficient state is untreated.

A combination of anemia, glossitis, and neurologic signs is particularly suggestive.

Slide 60 · The typical diagnostic laboratory pattern

Finding

Pathophysiologic interpretation

Megaloblastic macrocytic anemia

Impaired DNA synthesis

Leukopenia / hypersegmented neutrophils

Ineffective granulopoiesis

Low serum B12

Cobalamin depletion

High homocysteine + high methylmalonic acid

Impaired B12-dependent reactions

Slide 61 · Anti-intrinsic-factor testing identifies the etiology

Serum anti-intrinsic-factor antibodies are highly specific for pernicious anemia.

Antibody detection supports autoimmune intrinsic-factor dysfunction.

Not every patient has detectable antibodies; A negative result cannot rule out disease.

Anti-parietal-cell antibodies are less specific.

Slide 62 · B12 deficiency versus folate deficiency

Vitamin B12 deficiency

Folate deficiency

Megaloblastic blood and marrow changes

Same megaloblastic morphology

Homocysteine increased

Homocysteine increased

Methylmalonic acid increased

Methylmalonic acid normal

Neurologic injury can occur

Characteristic B12 neurologic injury absent

Slide 63 · Diagnostic integration: Blood, metabolites, and antibodies

Recognizemegaloblastosis

Document lowserum B12

Evaluate homocysteineand methylmalonate

Assess anti-IFantibodies

Use the history to assess dietary, gastric, pancreatic, ileal, and nitrous oxide mechanisms.

Interpret the biochemical findings with the clinical history and antibody results.

Slide 64 · Reticulocytosis documents early hematologic response

A marked reticulocyte response follows parenteral B12 therapy.

A rise in reticulocytes and hematocrit begins at approximately 5 days.

The response supports the diagnosis and corrects ineffective hematopoiesis.

Response to replacement should be interpreted alongside the underlying gastric etiology.

Slide 65 · Replacement corrects the deficit, not the autoimmunity

Parenteral B12 or high-dose oral B12 can treat the anemia.

Neurologic progression may improve or stop; Recovery can be incomplete.

Gastric atrophy and metaplasia are not reversed by cobalamin therapy.

Pernicious anemia therefore has implications beyond normalization of blood counts.

Slide 66 · Persistent gastric pathology confers cancer risk

Gastric mucosal atrophy and metaplasia persist despite B12 therapy.

Pernicious anemia is associated with increased gastric carcinoma risk.

The cancer risk is not erased by correcting the anemia.

This reflects the continuing significance of the underlying autoimmune gastric disease.

Slide 67 · Application case: Autoimmune deficiency

An older adult has macro-ovalocytes, hypersegmented neutrophils, low serum B12, and high methylmalonic acid. Anti-intrinsic-factor antibodies are detected.

What connects the gastric lesion to the blood findings?

Autoimmune fundic atrophy reduces parietal cells and intrinsic factor.

Ileal B12 uptake falls, causing cobalamin deficiency.

Impaired DNA synthesis produces ineffective, megaloblastic hematopoiesis.

Slide 68 · Application case: Neurologic presentation

A person with paresthesias and sensory ataxia has a B12-related biochemical abnormality, but lacks striking anemia.

Why does this not exclude clinically significant B12 deficiency?

Neurologic injury may occur without overt hematologic changes.

Spinal dorsal and lateral pathways can be affected.

Replacing folate alone does not protect against the neurologic deficit.

Slide 69 · Final synthesis: Three linked pathologies

Location / system

Defining lesion or consequence

Gastric body and fundus

Autoimmune atrophy → intrinsic factor loss

Bone marrow / peripheral blood

Defective DNA synthesis → megaloblastosis / cytopenias

Spinal cord / nerves

Demyelinating neurologic injury

Gastric mucosa over time

Persistent metaplasia and carcinoma risk

Slide 70 · Key conclusions

Pernicious anemia is the autoimmune-gastritis form of vitamin B12 deficiency.

Intrinsic-factor loss impairs terminal ileal uptake after a long latency.

Defective folate-dependent DNA synthesis causes megaloblastic hematopoiesis.

Neurologic injury and gastric cancer risk must be addressed independently of the anemia.